BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 1346086)

  • 1. [New prognostic factors in human gastric carcinomas].
    Yasui W; Nakayama H; Kuniyasu H; Ito M; Yokozaki H; Ito H; Tahara E
    Gan To Kagaku Ryoho; 1992 Jan; 19(1):26-33. PubMed ID: 1346086
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Biological malignancy in human gastric carcinoma--molecular aspects].
    Yasui W; Ito H; Yoshida K; Tahara E
    Gan To Kagaku Ryoho; 1991 May; 18(6):927-33. PubMed ID: 2029195
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Growth factors in progression of human esophageal and gastric carcinomas.
    Yoshida K; Yasui W; Ito H; Tahara E
    Exp Pathol; 1990; 40(4):291-300. PubMed ID: 2098274
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Frequent loss of heterozygosity on chromosomes 1q, 5q, and 17p in human gastric carcinomas.
    Sano T; Tsujino T; Yoshida K; Nakayama H; Haruma K; Ito H; Nakamura Y; Kajiyama G; Tahara E
    Cancer Res; 1991 Jun; 51(11):2926-31. PubMed ID: 2032230
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic pathways of two types of gastric cancer.
    Tahara E
    IARC Sci Publ; 2004; (157):327-49. PubMed ID: 15055305
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative study of tumor angiogenesis and immunohistochemistry for p53, c-ErbB2, c-myc and EGFr as prognostic factors in gastric cancer.
    Sanz-Ortega J; Steinberg SM; Moro E; Saez M; Lopez JA; Sierra E; Sanz-Esponera J; Merino MJ
    Histol Histopathol; 2000 Apr; 15(2):455-62. PubMed ID: 10809364
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Molecular diagnosis of gastric cancer].
    Yasui W; Yoshida K; Ito H; Tahara E
    Gan To Kagaku Ryoho; 1991 Jan; 18(1):7-13. PubMed ID: 1987903
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [New molecular prognostic markers in gastric carcinoma].
    Yoshida K; Yasui W; Yokozaki H; Nishimoto N; Kagawa Y; Toge T; Tahara E; Yoshida T; Terada M
    Gan To Kagaku Ryoho; 1998 Nov; 25(13):2021-7. PubMed ID: 9838902
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of epidermal growth factor (EGF) radioreceptor analysis on long-term survival of gastric cancer patients.
    Kopp R; Ruge M; Rothbauer E; Cramer C; Kraemling HJ; Wiebeck B; Schildberg FW; Pfeiffer A
    Anticancer Res; 2002; 22(2B):1161-7. PubMed ID: 12168918
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overexpression of p53 is associated with growth pattern and prognosis in advanced gastric cancer.
    Ichiyoshi Y; Oiwa H; Tomisaki S; Sakaguchi Y; Ohno S; Maehara Y; Sugimachi K
    Hepatogastroenterology; 1997; 44(14):546-53. PubMed ID: 9164535
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DNA ploidy, proliferative index, and epidermal growth factor receptor: expression and prognosis in patients with gastric cancers.
    D'Agnano I; D'Angelo C; Savarese A; Carlini M; Garofalo A; Bottari L; Santoro E; Giannarelli D; Vecchione A; Zupi G
    Lab Invest; 1995 Apr; 72(4):432-8. PubMed ID: 7723282
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic implications of altered human epidermal growth factor receptors (HERs) in gastric carcinomas: HER2 and HER3 are predictors of poor outcome.
    Begnami MD; Fukuda E; Fregnani JH; Nonogaki S; Montagnini AL; da Costa WL; Soares FA
    J Clin Oncol; 2011 Aug; 29(22):3030-6. PubMed ID: 21709195
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epidermal growth factor-receptor expression correlates with tumor cell proliferation and prognosis in gastric cancer.
    Jonjić N; Kovac K; Krasević M; Valković T; Ernjak N; Sasso F; Melato M
    Anticancer Res; 1997; 17(5B):3883-8. PubMed ID: 9427797
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of Cbl linking with the epidermal growth factor receptor system is associated with tumor progression and poor prognosis of human gastric carcinoma.
    Ito R; Nakayama H; Yoshida K; Matsumura S; Oda N; Yasui W
    Virchows Arch; 2004 Apr; 444(4):324-31. PubMed ID: 14991403
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A single nucleotide polymorphism in the 5' untranslated region of the EGF gene is associated with occurrence and malignant progression of gastric cancer.
    Hamai Y; Matsumura S; Matsusaki K; Kitadai Y; Yoshida K; Yamaguchi Y; Imai K; Nakachi K; Toge T; Yasui W
    Pathobiology; 2005; 72(3):133-8. PubMed ID: 15860930
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gene methylation in gastric cancer.
    Qu Y; Dang S; Hou P
    Clin Chim Acta; 2013 Sep; 424():53-65. PubMed ID: 23669186
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Metastasis-related genes].
    Yokozaki H; Tahara E
    Gan To Kagaku Ryoho; 1994 Nov; 21(15):2541-8. PubMed ID: 7526801
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The immunohistochemical expression of the p53-protein in gastric carcinomas. Correlation with clinicopathological factors and survival of patients.
    Lazăr D; Tăban S; Sporea I; Dema A; Cornianu M; Lazăr E; Goldiş A; Raţiu I; Vernic C
    Rom J Morphol Embryol; 2010; 51(2):249-57. PubMed ID: 20495739
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of metastasis in human gastric cancer cells transfected with tissue inhibitor of metalloproteinase 1 gene in nude mice.
    Watanabe M; Takahashi Y; Ohta T; Mai M; Sasaki T; Seiki M
    Cancer; 1996 Apr; 77(8 Suppl):1676-80. PubMed ID: 8608561
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Relationship of expression unbalance of matrix metalloproteinase and tissue inhibitor of metalloproteinase to invasiveness and metastasis in gastric carcinomas].
    Li L; Zhang S; Lin H; Lin JY
    Ai Zheng; 2002 Mar; 21(3):305-10. PubMed ID: 12452001
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.